SCHEMBL4900643

SCHEMBL4900643

CCN(Sc1ccc(OC(F)(F)F)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
PKM P14618 1/20 0.44
POLB P06746 1/20 0.43
HCRTR2 O43614 1/20 0.42
TRPM8 Q7Z2W7 9/20 0.41
CNR2 P34972 1/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
FFAR4 Q5NUL3 1/20 0.38
LMNA P02545 3/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905243 0.97 KDM4E (0.42) KDM4EALDH1A1PKMPOLBHCRTR2
SCHEMBL4904399 0.92 ALDH1A1 (0.46) KDM4EALDH1A1PKMHCRTR2TRPM8
SCHEMBL4906037 0.90 ALDH1A1 (0.44) KDM4EALDH1A1PKMHCRTR2TRPM8
SCHEMBL4906561 0.89 ALDH1A1 (0.44) KDM4EALDH1A1PKMHCRTR2FFAR4
SCHEMBL4905350 0.89 TRPM8 (0.40) KDM4EALDH1A1PKMHCRTR2TRPM8
SCHEMBL4906844 0.87 POLB (0.41) POLBLMNA
SCHEMBL4899866 0.86 LMNA (0.40) KDM4EALDH1A1POLBLMNAMEN1
SCHEMBL4902550 0.86 TRPM8 (0.38) KDM4EALDH1A1PKMHCRTR2TRPM8
SCHEMBL4905300 0.86 POLB (0.43) ALDH1A1POLBLMNASMN1; SMN2HTT
SCHEMBL4905969 0.86 POLB (0.43) KDM4EALDH1A1POLBLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KDM4E 3834/4885ALDH1A1 2956/4885PKM 861/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KDM4E 3834/4885ALDH1A1 2956/4885PKM 861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.